Gp350-anchored extracellular vesicles: promising vehicles for delivering therapeutic drugs of B cell malignancies
Although chimeric antigen receptor-modified (CAR) T cell therapy has been successfully applied in the treatment of acute B lymphocytic leukemia, its effect on Burkitt lymphoma (BL) and chronic B lymphocytic leukemia (B-CLL) is unsatisfactory. Moreover, fatal side effects greatly impede CAR T cell ap...
Saved in:
Main Authors: | Huiqing Xiu (Author), Xi Nan (Author), Danfeng Guo (Author), Jiaoli Wang (Author), Jiahui Li (Author), Yanmei Peng (Author), Guirun Xiong (Author), Shibo Wang (Author), Changjun Wang (Author), Gensheng Zhang (Author), Yunshan Yang (Author), Zhijian Cai (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Update on in Vivo Imaging of Extracellular Vesicles as Drug Delivery Vehicles
by: Prakash Gangadaran, et al.
Published: (2018) -
Extracellular Vesicles as Drug Targets and Delivery Vehicles for Cancer Therapy
by: Sai V. Chitti, et al.
Published: (2022) -
Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges
by: Rong Du, et al.
Published: (2022) -
Extracellular Vesicles, as Drug-Delivery Vehicles, Improve the Biological Activities of Astaxanthin
by: Young Jun Jang, et al.
Published: (2023) -
Doxorubicin Loading into Milk and Mesenchymal Stem Cells' Extracellular Vesicles as Drug Delivery Vehicles
by: Anindya Mukhopadhya, et al.
Published: (2023)